Coral Gables, Florida
Exosome supply and 503A pharmacy access for Coral Gables practices
ExaVeyra supplies research-use exosome material to licensed practices in Coral Gables from its base across the bay in Miami Beach, and because Florida is a state where the 503A pharmacy partner holds a non-resident license, a prescriber here can also send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly. This page covers what a Gables practice can source, how a local delivery works, and where the Florida law questions are answered.
It speaks to the practice, names no condition or use, and points to the Florida sourcing guide and the Miami logistics page for what the city does not change.
What a Coral Gables practice can source
| Material | Availability here |
|---|---|
| Exosome material | Available. Research-use exosome formats, characterised per lot, shipped cold-chain from Miami Beach to licensed practices in every state and Puerto Rico. |
| Compounded 503A preparations | Available. Prepared to an individual prescription by our 503A pharmacy partner, which holds a non-resident pharmacy license for Florida, and dispensed by that pharmacy to the patient named on the prescription. |
| Documentation | A lot-specific certificate of analysis is available on request for every exosome lot; compounded preparations carry the pharmacy label and beyond-use date. |
The practice landscape in Coral Gables
Coral Gables is the academic medical centre of South Florida as much as it is a residential enclave: the University of Miami's main campus sits within the city, the UHealth system and the Miller School of Medicine are minutes away in the Civic Center, and Doctors Hospital, part of Baptist Health, anchors the south end of the city. That proximity gives the Gables a private-practice population weighted toward physician-owned dermatology, plastic surgery and concierge internal medicine groups, many of them with academic affiliations, concentrated along the Ponce de Leon Boulevard and Miracle Mile corridor and in the medical office buildings near Doctors Hospital.
The city's planning code, which has kept the Mediterranean Revival character of the downtown, also means that practice space is in low-rise office buildings and converted residences rather than in towers, and that a delivery address is often a suite in a small building with a front desk that keeps office hours. South Miami, Pinecrest and Key Biscayne, each with its own concierge and aesthetic base, are served on the same lane, and the Gables address is within the Miami-Dade ZIP range the Miami page describes.
The Gables also hosts a large number of specialists who split their week between a hospital appointment and a private office, and a practice like that should decide at account setup which address receives material and who is present there on delivery days. Ordering against the office calendar rather than the hospital calendar avoids the most common cause of a missed handover in this part of the county, a package arriving at a suite whose physician is on the hospital campus that afternoon.
Beyond the medical corridor, the Gables is home to a large professional-services and consular population around Alhambra Circle and Giralda Avenue, and a Latin American clientele who consult specialists here while visiting the city, which is why many Gables practices are bilingual and why the Spanish versions of these pages, when they publish, will matter more here than almost anywhere else the site serves. The Coral Gables Hospital campus on Douglas Road adds a second inpatient anchor at the city's northern edge.
The hair and scalp literature, for Coral Gables practices
The hair and scalp series on this site sets out, component by component, what the peer-reviewed literature and the FDA say about each formulation class the literature discusses. What follows is what that means for sourcing in this market.
The hair and scalp series on this site is the evidence reference for each formulation class the literature discusses, and for a Coral Gables practice the sourcing position is that research-use exosome formats are supplied on the practice's verified account, and the compounded preparations the pharmacy partner prepares are dispensed by that pharmacy against individual prescriptions, so the two travel separately under their own regimes. The evidence pages set out the literature and the FDA communications for each component, and the product category lists what the pharmacy partner prepares to prescription.
A practice with an academic affiliation sometimes asks whether research-use exosome material can be used in an institutional study. It can be purchased for research, and the study design, the institutional review and the consent are the institution's matters; ExaVeyra supplies the material and its characterisation documents and takes no part in the protocol.
How material reaches Coral Gables
Cold-chain shipments dispatch from the Miami Beach facility under continuous temperature monitoring and reach Florida practices in 1 to 3 business days, scheduled to avoid a weekend hold at the carrier hub.
Florida destinations sit on the shortest lane ExaVeyra runs, and cold-chain shipping is free to Florida destinations from 6 units against 15 units nationwide; the threshold is applied by the cart rather than quoted case by case.
Florida law is a separate question, answered in the state guide
What a Florida practice may offer, who in the practice may handle material, whether the state has a stem cell or regenerative-medicine statute and how any such statute reads against an acellular preparation, and which boards verify a license are covered in the Florida sourcing guide rather than repeated here. Nothing about the city changes any of it.
Coral Gables sourcing questions
- How is material delivered to a Coral Gables practice?
- The Gables sits inside the Miami-Dade delivery range served from the Miami Beach base, so an order is either delivered locally on the Florida lane or collected by arrangement with the ExaVeyra team. The Miami page states the fulfilment window and the free cold-chain threshold for Florida destinations. A suite in a low-rise building should name the person who will sign for the package, because a cold-chain delivery left with a building front desk that closes at midday is the most common cause of an excursion in this part of the county.
- Can a research institution purchase research-use exosome material?
- A licensed practice or an institution with a research programme can apply. The material is supplied with its lot characterisation and a certificate of analysis available on request, and how it is used in a study is governed by the institution's review process and by federal law, which ExaVeyra does not interpret for a buyer. The regulatory pages on this site describe the FDA's position on exosome products.
- Are South Miami, Pinecrest and Key Biscayne served the same way?
- Yes. Each is a Miami-Dade address on the same Florida lane, with the same compounding availability and the same account structure, and a group with more than one location can list every delivery address on one account so lots trace to the site that received them.
Sources
- Miami-Dade County, official site (accessed 15 September 2026)
- Florida Board of Medicine (accessed 15 September 2026)
- Florida Department of Health, license verification (accessed 15 September 2026)
Last reviewed 17 September 2026 by Benn Bluestein-Veyra, M.Sc. Organic Chemistry. Availability is read from the state registry at the time of the request.
These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Exosome material distributed by ExaVeyra Sciences is supplied for Research Use Only, for medical, molecular biology, and biochemistry research applications, and ExaVeyra Sciences makes no statement about administration, route, or outcome. Compounded medications are a separate product class: they are not FDA-approved finished drug products, they are prepared under section 503A of the Federal Food, Drug, and Cosmetic Act against a prescription for an individual patient, and they are prescription products rather than research-use-only material. ExaVeyra does not supply controlled substances. This page is provided for informational purposes only. It is not medical advice, it is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for the judgment of a licensed practitioner. Consult a healthcare professional before acting on anything stated here. The FDA has not approved GHK-Cu or any exosome product for hair loss or any form of alopecia. Compounded medications are not FDA-approved; they are prepared by a licensed 503A compounding pharmacy for an individual patient against that patient’s prescription, and they are supplied to NPI-verified licensed practitioners only. Where this page discusses an FDA-approved active such as oral finasteride or topical minoxidil, the approved product’s labeling governs and nothing here modifies it. ExaVeyra Sciences is a supplier and takes no part in any diagnosis, treatment decision, or plan of care. ExaVeyra Sciences does not supply controlled substances. Findings described on this page are attributed to the peer-reviewed literature and to the agencies cited, and a citation establishes that a question was studied, not that any product is suitable for a given patient. The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here. Exosome material is supplied for Research Use Only. No exosome product is FDA-approved for any use, and ExaVeyra Sciences makes no statement about administration, route, or outcome.
Reference only. Not legal or medical advice.
The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here.
Read the full disclaimer
ExaVeyra Sciences publishes these guides as a reference for licensed practitioners. They summarize publicly available federal and state requirements as those requirements read on the review date shown above. The content is provided for general informational purposes only and does not constitute legal, medical, or regulatory advice, and it does not establish that any particular product or practice is compliant.
No attorney-client relationship, and no professional or clinical relationship of any kind, is created by accessing these materials. ExaVeyra Sciences is a supplier of research-use materials. It is not a law firm, it is not a regulatory consultant, and it takes no part in any diagnosis, treatment decision, or plan of care. Each practitioner is responsible for retaining their own legal counsel and for determining, with that counsel and the applicable state licensing boards, how the requirements described here apply to the services, staffing, and structure of their own practice.
Statutes, regulations, board rules, and agency positions are subject to amendment, supersession, and reinterpretation. ExaVeyra Sciences makes no representation or warranty as to the accuracy, completeness, timeliness, or applicability of this content to any particular practice. Citations and links to third-party sources are provided for convenience only and do not constitute an endorsement of their content.
The practitioner and the practice are solely responsible for compliance with all applicable licensing, scope of practice, supervision, ownership, facility, recordkeeping, and tax requirements, and for all clinical decisions, including the suitability of any material for a given patient. To the fullest extent permitted by law, ExaVeyra Sciences disclaims all liability for any action taken or not taken in reliance on this content.